Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3709741012 | Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3709742017 | Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Efavirenz- and emtricitabine- and tenofovir-containing product | true | Inferred relationship | Some | ||
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Efavirenz-containing product in oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Is a | Emtricitabine- and tenofovir-containing product in oral dose form | true | Inferred relationship | Some | ||
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Efavirenz | true | Inferred relationship | Some | 1 | |
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Emtricitabine | true | Inferred relationship | Some | 2 | |
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Has active ingredient | Tenofovir | true | Inferred relationship | Some | 3 | |
Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Efavirenz and emtricitabine and tenofovir only product in oral dose form | Is a | True | Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Inferred relationship | Some | |
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet | Is a | False | Efavirenz- and emtricitabine- and tenofovir-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets